C8 substituted purine nucleotide inhibitors (Bar-Ilan)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC8 substituted purine nucleotide inhibitors (Bar-Ilan)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBar Ilan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBar-Ilan Research & Development Co LtdBar Ilan University
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A